Table 1. Correlations between expression of CXCR4 and clinicopathological features.
| Characteristics | n (%) | CXCR4 | χ2 | P | |
| Positive | Negative | ||||
| Age(yrs.) | |||||
| <47 | 27 (44.26) | 14 | 13 | ||
| >47 | 34 (55.74) | 23 | 11 | 1.573 | 0.322 |
| FIGO stage | |||||
| I-II | 18 (29.51) | 15 | 3 | ||
| III-IV | 43 (70.49) | 22 | 21 | 5.503 | 0.019 |
| Tumor grade | |||||
| I | 26 (42.62) | 11 | 15 | ||
| II-III | 35 (57.38) | 26 | 9 | 6.392 | 0.011 |
| Lymphatic metastasis | |||||
| Positive | 40 (65.57) | 30 | 10 | ||
| Negative | 21 (34.43) | 7 | 14 | 10.018 | 0.002 |
| Peritoneal cytology | |||||
| Positive | 38 (62.30) | 27 | 11 | ||
| Negative | 23 (37.70) | 10 | 13 | 4.565 | 0.033 |